RECURRENT LUNG NON-SMALL CELL CARCINOMA
Clinical trials for RECURRENT LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mayo clinic tests higher radiation dose to control tough lung cancers
Disease control CompletedThis study tested whether a higher dose of proton beam radiation works better than a standard dose when combined with chemotherapy for patients with inoperable stage 2 or 3 non-small cell lung cancer. Twenty patients were randomly assigned to receive either 60 Gy or 72 Gy of prot…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Three-Drug attack on tough lung cancer tested in small trial
Disease control CompletedThis study tested a combination of three drugs—durvalumab, tremelimumab, and selumetinib—for people with advanced or returning non-small cell lung cancer. The goal was to see if using these drugs together could help the immune system fight the cancer and slow its growth better th…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC